Zenotech Laboratories

Zenotech Laboratories CROIC

The Cash Return on Invested Capital (CROIC) of Zenotech Laboratories (532039.BO) as of Oct 15, 2026 is 1.98 %. In the previous year, Cash Return on Invested Capital (CROIC) was 5.85 % — a change of -66.18% (lower).

CROIC

1.98 %

YoY

-66.18%

Last updated:

Cash Return on Invested Capital (CROIC) of Zenotech Laboratories is 2026 1.98 % . Cash Return on Invested Capital (CROIC) of Zenotech Laboratories was 2025 5.85 % . It decreases by -66.18% lower compared to the previous year.

The Zenotech Laboratories CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2019
-54.24 INR
Jan 1, 2020
-15.18 INR
Jan 1, 2021
1.20 INR
Jan 1, 2022
20.52 INR
Jan 1, 2023
17.54 INR
Jan 1, 2024
8.38 INR
Jan 1, 2025
5.85 INR
Jan 1, 2026
1.98 INR
The Zenotech Laboratories CROIC history
YEARCROICYoY
1.98 %-66.18%
5.85 %-30.19%
8.38 %-52.22%
17.54 %-14.53%
20.52 %+1,608.86%
1.20 %-107.91%
-15.18 %-72.01%
-54.24 %+13.52%
-47.78 %+656.37%
-6.32 %-93.24%
-93.41 %+230.19%
-28.29 %-34.95%
-43.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd, listed on the Bombay Stock Exchange with ticker 532039.BO and ISIN INE486F01012, is a biotechnology company operating in the healthcare sector. Headquartered in Hyderabad, India, the company employs 150 full-time staff. Founded through an IPO on May 14, 1996, Zenotech focuses on the manufacturing and marketing of pharmaceutical products, specifically specializing in specialty generic injectables. Its production facilities are located in Turkapally village, Shamirpet Mandal, Telangana. The company's product portfolio includes oncology, biotechnology, and general injectables. Zenotech Laboratories Ltd maintains a website at http://zenotechlab.com/ for further information. The firm's operations are centered around the development and distribution of injectable pharmaceutical solutions, targeting both domestic and international markets. With its focus on injectables, the company aims to provide accessible and reliable healthcare products. The company's headquarters in Hyderabad serves as the central hub for its business activities, including research, development, and administrative functions. Zenotech's business model emphasizes the production of generic injectables, which are critical for various medical treatments, particularly in oncology and biotechnology sectors. The company's presence in the Telangana region, with its manufacturing facility in Turkapally, underscores its commitment to local manufacturing and supply chain efficiency. As a publicly traded entity, Zenotech Laboratories Ltd. provides investors with exposure to the biotechnology and pharmaceutical sectors within India's healthcare industry. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Cash Return on Invested Capital (CROIC) of Zenotech Laboratories is 1.98 % in 2026.

Cash Return on Invested Capital (CROIC) of Zenotech Laboratories changed from 5.85 % to 1.98 %, representing a -66.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Zenotech Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Zenotech Laboratories

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Zenotech Laboratories